Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yoles

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Ophthalmology|June 10, 2000
Neuroprotection: a new treatment modality for glaucoma?M Schwartz, E Yoles
European Journal of Ophthalmology|May 7, 1999
Optic nerve degeneration and potential neuroprotection: implications for glaucomaM Schwartz, E Yoles
Survey of Ophthalmology|March 11, 1998
Potential neuroprotective therapy for glaucomatous optic neuropathyE Yoles, M Schwartz
Acta Neurochirurgica. Supplement|July 1, 2005
Macrophages and dendritic cells treatment of spinal cord injury: from the bench to the clinicM Schwartz, E Yoles
Experimental Neurology|September 23, 1998
Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathiesE Yoles, M Schwartz
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 31, 1998
Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerveE Yoles, M Schwartz
Investigative Ophthalmology & Visual Science|February 12, 2000
Self-destructive and self-protective processes in the damaged optic nerve: implications for glaucomaM Schwartz, E Yoles
Journal of Neurotrauma|January 1, 1996
HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomyE Yoles, M Belkin, M Schwartz
Journal of Neurochemistry|February 7, 2001
Thrombin attenuation is neuroprotective in the injured rat optic nerveI Friedmann, E Yoles, M Schwartz
Advances in Experimental Medicine and Biology|January 1, 1986
Metabolic, ionic and electrical responses to oxygen deficiency in the newborn dog in vivoA Mayevsky, E Yoles, N Zarchin
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Ophthalmology|June 10, 2000
Neuroprotection: a new treatment modality for glaucoma?M Schwartz, E Yoles
European Journal of Ophthalmology|May 7, 1999
Optic nerve degeneration and potential neuroprotection: implications for glaucomaM Schwartz, E Yoles
Survey of Ophthalmology|March 11, 1998
Potential neuroprotective therapy for glaucomatous optic neuropathyE Yoles, M Schwartz
Acta Neurochirurgica. Supplement|July 1, 2005
Macrophages and dendritic cells treatment of spinal cord injury: from the bench to the clinicM Schwartz, E Yoles
Experimental Neurology|September 23, 1998
Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathiesE Yoles, M Schwartz
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 31, 1998
Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerveE Yoles, M Schwartz
Investigative Ophthalmology & Visual Science|February 12, 2000
Self-destructive and self-protective processes in the damaged optic nerve: implications for glaucomaM Schwartz, E Yoles
Journal of Neurotrauma|January 1, 1996
HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomyE Yoles, M Belkin, M Schwartz
Journal of Neurochemistry|February 7, 2001
Thrombin attenuation is neuroprotective in the injured rat optic nerveI Friedmann, E Yoles, M Schwartz
Advances in Experimental Medicine and Biology|January 1, 1986
Metabolic, ionic and electrical responses to oxygen deficiency in the newborn dog in vivoA Mayevsky, E Yoles, N Zarchin
Pageof 5